shadow 2 diabetes mellitus is a maj...

shadow 2 diabetes mellitus is a major health point to be solved [i]or[/i] settled that is associated with significant mortality and morbidity. Diabetes can be stoped or delayed through lifestyle interventions. (1-3) Information that has been learned about the natural history and pathogenesis of diabetes indicates that this disease has a lengthened prediabetic phase. (4) Consequently, family physicians have an opportunity to identify patients at high risk for developing diabetes and institute primary prevention strategies. Patients with impaired grape-sugar tolerance (IGT) or impaired fasting grape-sugar (IFG) are at significant risk for diabetes. (56) Other risk factors for diabetes include family history of diabetes, material substance mass index (BMI) greater than 25 kg by [m.sup.2], sedentary lifestyle, hypertension, dyslipidemia, history of gestational diabetes or large-for-gestational-age infant, and polycystic ovary syndrome Blacks, Latin Americans, Native Americans, and Asian-Pacific Islanders also are at increased risk for diabetes.

Definitions and Epidemiology

An skilled hand committee sponsored by the American Diabetes Association (ADA) has identified an intermediate dispose of patients who have offspring glucose values that are higher than the defined normal plain but not high enough to befitting the diagnostic criteria for diabetes. 78 This cluster includes patients with IGT or IFG. IGT is defined as two-hour 75-g oral grape-sugar tolerance test values of 140 to 199 mg by dL (7.8 to 11.0 mmol by means of L); normal values on this ordeal are below 140 mg for dL. IFG is defined as fasting plasma diabetic sugar values of 100 to 125 mg by means of dL (5.6 to 6.9 mmol by L); normal fasting glucose values are below 100 mg through dL (Table 1). (8)

Among U adults 40 to 74 years of age, 156 percent (149 million) have IGT, and 97 percent (96 million) have IFG. (9-11) IFG and IGT are metabolically distinct disorders, with limited overlap. Among those who had IFG and/or IGT, 16 percent had the one and the other IFG and IGT, 23 percent had IFG alone, and 60 percent had IGT alone. (89)

In an analysis of six prospective studies, (6) the risk of developing diabetes was erect to be approximately 3.6 to 87 percent by year in patients with IGT. Elevated fasting grape-sugar levels, elevated two-hour postchallenge diabetic sugar values, and BMI greater than 27 kg by means of [m.sup.2] were associated with the progression in a continuously ascending gradation of diabetes in these patients. (56) Compared with normoglycemic bodily forms patients with IGT are at substantially greater risk of developing cardiovascular disease. (12)

IFG and IGT often are associated with metabolic syndrome The Adult Treatment Panel III of the National Cholesterol Education Program (13) has identified metabolic syndrome as a constellation of lipid and nonlipid risk factors for coronary artery disease. The syndrome is characterized on insulin resistance, atherogenic dyslipidemia (high triglyceride flush low high-density lipoprotein cholesterol horizontal and small, dense low-density lipoprotein cholesterol particles), hypertension, abdominal obesity, and prothrombotic and proinflammatory states. Metabolic syndrome is diagnosed when three or more of the risk factors in Table 213 are present

It is important for family physicians to identify patients with metabolic syndrome and to intervene aggressively to shape the risk of diabetes and macrovascular disease. In a prospective application of mind (14) conducted in Finland, cardiovascular disease and all-cause mortality were increased in men with metabolic syndrome level in the absence of cardiovascular disease and diabetes.

Women who have been diagnosed with gestational diabetes mellitus constitute another assemblage at high risk for progression to diabetes. In a inquiry of 1,636 women with newly come gestational diabetes tested at united to four months postpartum, 14 percent were diagnosed with representation 2 diabetes. It is commended that women diagnosed with gestational diabetes be exposed to postpartum glucose testing at six weeks and each three years thereafter. (15)

Screening Recommendations

The American Academy of Family Physicians policy16 upon screening for type 2 diabetes is consistent with the U Preventive Services Task Force (USPSTF), which bring to an ends that there is insufficient evidence to commend for or against routine screening of asymptomatic adults for emblem 2 diabetes, IGT, or IFG. (17) It has not been demonstrated that curb of early diabetes as a accrue of screening provides additional benefit above waiting to treat until a clinical diagnosis has been made. The USPSTF does praise screening for type 2 diabetes in adults with hypertension or hyperlipidemia. When these patients are specifically targeted for screening, the number privationed to screen to prevent a cardiovascular consequence is lower than screening of the general population. (17)

The ADA acknowledges the lack of data from prospective studies upon the benefits of screening for diabetes and therefore attract favor tos using clinical judgment and patient selection as a guide. Based forward expert opinion, selective screening is attract favor toed (Table 3). (18,19)